Jagsonpal Pharmaceuticals informs about revised investor presentation

24 Oct 2024 Evaluate
In continuation to its earlier intimation dated October 23, 2024, Jagsonpal Pharmaceuticals has informed that it enclosed a copy of revised Investor Presentation for the Unaudited Financial results for the quarter and half year ended September 30, 2024, due to an inadvertent error in slide 20 which has been rectified.

The above information is a part of company’s filings submitted to BSE.

Jagsonpal Pharma Share Price

640.20 48.55 (8.21%)
22-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1797.80
Dr. Reddys Lab 1213.90
Cipla 1486.30
Lupin 2069.95
Zydus Lifesciences 948.70
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.